4
Changes in Ownership
Aprea Therapeutics, Inc. Filed Acc 0001104659-22-033392
SVP, Chief Business Officer gave up 1,989 shares (to pay taxes)
- SVP, Chief Business Officer acquired 16,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Korbel Gregory Alan SVP, Chief Business Officer | 2022-03-10 | Grant or award | +16,000 | 31,841 | D | ||
| Korbel Gregory Alan SVP, Chief Business Officer | 2022-03-10 | Shares withheld for taxes | −1,989 | $1.82 | $3,620 | 29,852 | D |
| Derivatives | |||||||
| Korbel Gregory Alan SVP, Chief Business Officer | 2022-03-10 | Grant or award · Stock Option (right to Buy) | +72,600 | 72,600 | D | ||
Loading xslF345X03/tm229119-4_4seq1.xml…